Novel Phase I dose de-escalation design trial to determine the biological modulatory dose of the antiangiogenic agent SU5416.
| Image |  |
|---|---|
| Description | scientific article published in November 2005 |
| Author/s |
author: Tomas Radivoyevitch |
| Publication date | November 1, 2005 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |